Stock listing

KRX:115180 Qurient Co., Ltd. (큐리언트) 주가

Follow Qurient Co., Ltd. into a list and get an email when it puts out news.

Share price · KRX:115180

₩13,180 KRW +150 (+1.2%)

Close on Nov 20, 2026

Past year -50.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₩13,060 – ₩14,500 KRWNov 20, 2026
Volume
449,311 sharesNov 20, 2026
Market cap
₩519.7B KRWAt the close on Nov 20, 2026 · price × 39.43M shares outstanding
52-week range
₩12,890 – ₩62,900 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₩3.63B KRWMedian day 138,545 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Qurient Co., Ltd. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:115180 · KRW, adjusted for splits

DayCloseChange%OpenHighLowVolume
₩13,180+150+1.2%₩13,880₩14,500₩13,060449,311
₩13,030-120-0.9%₩13,160₩13,540₩12,890184,638
₩13,150-270-2.0%₩13,300₩13,550₩13,010128,104
₩13,420-1,090-7.5%₩14,500₩14,720₩13,350146,419
₩14,510-1,930-11.7%₩16,200₩16,800₩14,450246,036
₩16,440+620+3.9%₩15,630₩16,860₩15,330185,679
₩15,820+30+0.2%₩15,580₩16,110₩15,420211,552
₩15,790+970+6.5%₩15,730₩15,980₩14,880110,128
₩14,820-490-3.2%₩15,130₩15,600₩13,950118,909
₩15,310-1,680-9.9%₩15,300₩16,130₩15,120172,906
₩16,990+750+4.6%₩16,600₩19,220₩16,600180,181
₩16,240+400+2.5%₩15,870₩16,540₩15,100140,426
₩15,840-970-5.8%₩16,700₩16,700₩15,400112,147
₩16,810+220+1.3%₩16,650₩17,130₩15,900129,860
₩16,590-1,240-7.0%₩17,410₩17,640₩16,40078,238
₩17,830-140-0.8%₩17,750₩18,190₩17,30097,136
₩17,970-470-2.5%₩18,530₩18,530₩17,000149,001
₩18,440-630-3.3%₩19,260₩19,590₩18,000136,664
₩19,070-400-2.1%₩19,620₩20,250₩18,20095,773
₩19,470-730-3.6%₩19,710₩20,150₩19,22061,192
₩20,200-1,450-6.7%₩21,900₩21,900₩19,940119,213
₩21,650+1,650+8.3%₩20,000₩22,350₩19,860171,392
₩20,000+700+3.6%₩19,550₩20,000₩18,720112,392
₩19,300-2,200-10.2%₩19,950₩20,400₩18,950125,255
₩21,500+700+3.4%₩20,600₩22,150₩19,520136,583
₩20,800-600-2.8%₩21,300₩21,650₩20,150160,419
₩21,400+1,800+9.2%₩20,600₩22,300₩19,800346,653
₩19,600-2,250-10.3%₩22,700₩22,700₩19,000484,493
₩21,850-500-2.2%₩22,350₩23,350₩21,550113,428
₩22,350-1,850-7.6%₩23,450₩24,000₩20,800203,122
₩24,200-800-3.2%₩24,600₩25,500₩23,85072,412
₩25,000+250+1.0%₩24,900₩25,800₩24,050115,347
₩24,750+100+0.4%₩25,050₩25,200₩24,15059,268
₩24,650+2,650+12.0%₩22,250₩25,150₩22,250216,411
₩22,000+500+2.3%₩21,500₩22,600₩21,30039,583
₩21,500-1,050-4.7%₩22,800₩22,850₩21,35072,547
₩22,550-50-0.2%₩23,050₩23,350₩22,40052,973
₩22,600+100+0.4%₩22,650₩23,000₩22,35047,090
₩22,500+300+1.4%₩22,200₩22,850₩21,70090,826
₩22,200+800+3.7%₩22,100₩22,700₩21,60059,341
₩21,400-1,000-4.5%₩22,400₩22,600₩21,40087,269
₩22,400+450+2.1%₩22,000₩23,600₩21,500118,824
₩21,950+100+0.5%₩21,500₩22,150₩21,05039,269
₩21,850-250-1.1%₩21,800₩23,000₩21,35078,114
₩22,100+300+1.4%₩21,150₩22,700₩21,150101,435
₩21,800+50+0.2%₩21,050₩22,050₩20,75091,239
₩21,750-750-3.3%₩22,050₩22,200₩20,900144,637
₩22,500-450-2.0%₩22,500₩23,000₩21,550175,430
₩22,950-2,800-10.9%₩25,400₩25,600₩22,650246,754
₩25,750+2,700+11.7%₩22,700₩26,250₩22,350354,426
₩23,050+3,400+17.3%₩19,960₩23,300₩18,830658,970
₩19,650-850-4.1%₩20,800₩21,150₩19,540284,229
₩20,500-850-4.0%₩20,700₩21,800₩20,500196,556
₩21,350+800+3.9%₩20,350₩21,700₩20,150180,418
₩20,550+250+1.2%₩19,400₩20,650₩18,170219,337
₩20,300-2,000-9.0%₩21,700₩21,700₩19,680389,292
₩22,300-3,350-13.1%₩25,350₩25,450₩20,450649,613
₩25,650+600+2.4%₩24,900₩26,650₩24,900221,444
₩25,050-1,300-4.9%₩25,700₩26,000₩23,500175,936
₩26,350+1,550+6.3%₩25,450₩27,950₩25,250380,299
₩24,800-1,250-4.8%₩25,200₩26,050₩23,700161,311
₩26,050+800+3.2%₩26,900₩27,500₩24,900120,511

Splits

2 splits since 2023 · KRX:115180 · every price before a split is adjusted for it

DayRatioWhat
13-for-10Split
95-for-82Split
Ticker
KRX:115180
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
KRX
Currency
KRW

Latest news

All Qurient Co., Ltd. news

Qurient Co., Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
1 in all · newest Sep 25, 2025 · oldest 2025

Valuation

EV/sales 70.5× against a median of 32.5×: the highest of 5 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
₩498.2B KRW
P/E
Loss
EV/sales
70.5×
EV/EBITDA
Negative EBITDA
Price/book
30.2×
Gross margin
11.5%
Operating margin
−520.4%
Net margin
−543.0%
Debt to equity
0.8×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Qurient Co., Ltd. · KRX:115180US$388.5MUS$372.4Mn/a70.5×n/a30.2×−543.0%0.8×n/a
Candel Therapeutics, Inc. · NASDAQ:CADLUS$395.4MUS$193.8Mn/an/an/a3.0×n/a0.0×2.03
Ever Supreme Bio Technology Co., Ltd. · TPEX:6712US$394.8MUS$362.8M27.5×11.1×23.9×4.6×43.8%0.0×n/a
Mezzion Pharma Co., Ltd. · KRX:140410US$391.0MUS$360.8Mn/a57.3×n/a13.4×−325.0%0.0×n/a
Avalo Therapeutics, Inc. · NASDAQ:AVTXUS$390.9M−US$1.93Mn/an/an/a0.9×n/a0.0×1.25
Beijing Luzhu Biotechnology Co., Ltd. Class H · HKEX:2480US$388.2MUS$369.1Mn/an/an/a4.3×n/a0.4×n/a
Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H · HKEX:3378US$387.5MUS$316.0Mn/an/an/a4.1×n/a0.1×n/a
Opus Genetics, Inc. · NASDAQ:IRDUS$385.7MUS$332.3Mn/a42.0×n/a10.0×n/a0.9×1.01
Eupraxia Pharmaceuticals, Inc. · TSX:EPRXUS$384.3MUS$252.7Mn/an/an/a2.9×n/a0.0×1.53
Hinova Pharmaceuticals, Inc. Class A · SSE:688302US$381.1MUS$285.9Mn/a23.0×n/a2.6×−167.3%0.1×n/a
Rezolute, Inc. · NASDAQ:RZLTUS$379.2MUS$289.9Mn/an/an/a4.4×n/a0.0×1.28
Median of the othersUS$387.9MUS$303.0M27.5×32.5×23.9×4.2×−167.3%0.0×1.28

Events

QuarterResultsShare move
Q1 2025May 12, 2025 · After close+0.9%
Q3 2024Nov 7, 2024 · After close−2.4%
Quarter to Dec 31, 2022Mar 17, 2023 · After close+0.7%
Quarter to Sep 30, 2022Nov 14, 2022 · After close−5.3%
Quarter to Jun 30, 2022Aug 16, 2022 · Before open
Quarter to Mar 31, 2022May 16, 2022 · After close
Quarter to Sep 30, 2021Nov 15, 2021 · After close
Quarter to Jun 30, 2021Aug 17, 2021 · After close
Q1 2021May 14, 2021 · After close

Open Events

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue6.98B9.18B9.03B8.47B4.89B000
Cost of revenue6.05B7.83B7.27B6.69B4.00B000
Gross profit929.9M1.35B1.76B1.78B885.2M000
Research and development21.5B20.4B16.8B19.7B16.4B12.5B7.58B6.05B
Selling, general and administrative3.69B7.53B7.39B8.85B3.73B6.78B5.09B4.04B5.05B4.91B
Operating income-29.8B-27.5B-23.2B-27.5B-24.2B-21.0B-23.2B-16.7B-12.7B-11.1B
Depreciation and amortization961.2M579.8M539.6M444.3M665.2M540.6M444.6M58.3M69.6M100.6M
EBITDA-28.8B-26.9B-22.7B-27.0B-23.6B-20.5B-22.7B-16.6B-12.7B-11.0B
Interest expense310.5M27.8M18.6M26.0M36.6M00000
Income before tax-31.3B-24.5B-22.2B-27.1B-23.9B-20.8B-22.7B-16.4B-12.2B-10.5B
Income tax-13.2M13.2M0
Net income-30.1B-23.6B-21.1B-25.5B-22.8B-20.5B-22.7B-16.4B-12.2B-10.5B
Earnings per share, basic-808.20-729.92-794.91-1,389.37-1,707.78

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents21.0B1.85B1.94B20.6B18.5B570120-8103001.42B
Short-term investments29.0B33.1B7.87B12.5B33.4B34.9B9.89B2.00B
Receivables536.8M1.09B1.13B645.3M1.63B268.0K29.7M120.2M28.5M
Inventory46.3M97.0M170.5M146.7M153.7M
Current assets51.6B50.6B44.4B34.2B53.9B58.8B18.9B42.4B15.2B25.8B
Property, plant and equipment915.2M368.7M798.7M1.02B838.8M64.0M104.7M171.6M
Goodwill666.7M934.7M934.7M934.7M934.7M
Total assets62.0B65.6B52.5B38.4B57.6B60.8B20.5B43.2B15.7B26.2B
Accounts payable336.4M113.2M56.8M396.6M285.7M
Current liabilities3.90B5.01B2.33B2.95B2.76B2.70B2.49B3.73B1.13B1.79B
Long-term debt12.3B000
Total debt755.8M460.9M
Total liabilities22.8B7.97B5.88B3.28B3.55B4.24B3.14B3.79B1.15B1.89B
Shareholders' equity34.0B57.6B46.6B31.0B51.6B56.6B17.4B39.4B14.5B24.3B
Shares outstanding37.2M32.3M26.6M18.3M13.4M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-28.7B-23.3B-22.0B-25.0B-24.4B-19.8B-24.0B-13.8B-12.6B-9.90B
Capital spending-3.70B-83.7M-101.1M-518.6M-259.8M-10.7M-12.5M-432.1M-72.8M-50.3M
Free cash flow-32.4B-23.4B-22.1B-25.5B-24.6B-19.9B-24.0B-14.2B-12.7B-9.95B
Cash from investing-24.1B4.15B21.0B-39.1B20.4B-25.1B-7.54B-1.58B
Cash from financing26.8B31.5B6.27B59.9B-6.39M41.2B1.54B31.8B
Dividends paid-69.4M-70.0M
Share buybacks21.4B28.7B6.77B60.2B318.9M41.2B1.54B31.8B
Change in cash6.02B-19.9B14.3B2.13B13.8B906.4M-3.62B2.31B-18.6B20.4B

Open Financials

Cap table

Built by 6ix from Qurient Co., Ltd.’s releases

Common shares
39,433,948
Fully diluted
39,433,948

Fully diluted

LineShares
Common shares39,433,948

Share count over time

CountShares
Nov 22, 202639,433,948

Open Cap table

Shareholders

Open Shareholders

Log in to ask 6ix AI your own questions about Qurient Co., Ltd.